GlassScriptPhysician profile
Rodney F Pommier
NPI 1114932613
$24,018.40
in general payments reported to CMS, 2019-2025
8 companies · $189 in 2025
The $189 reported for 2025 was less than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $5,240 · 2021: $6,415 · 2023: $133 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $321.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Accelerator Applications | $7,756.86 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $7,346.85 | 2019-2023 | |
| Tersera Therapeutics LLC | $6,573.01 | 2021-2025 | Xermelo |
| Lexicon Pharmaceuticals, INC. | $2,015.19 | 2019-2020 | |
| Covidien LP | $128.27 | 2019 | |
| Ethicon US, LLC | $68.32 | 2021-2025 | Echelon; Endopath, Ethicon |
| Stryker Corporation | $68.00 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $61.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodney Pommier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.